CT Perfusion Can Predict Overexpression of CXCL8 (Interleukin-8) in Head and Neck Squamous Cell Carcinoma

REFERENCES

1. 1.↵
   1. Ash L,
   2. Teknos TN,
   3. Gandhi D,
   4. et al

   . Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology 2009;251:422–28

   CrossRefPubMed
2. 2.↵
   1. Delrue L,
   2. Blanckaert P,
   3. Mertens D,
   4. et al

   . Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging. J Comput Assist Tomogr 2011;35:434–38

   CrossRefPubMed
3. 3.↵
   1. Afaq A,
   2. Akin O

   . Imaging assessment of tumor response: past, present and future. Future Oncol 2011;7:669–77

   CrossRefPubMed
4. 4.↵
   1. Jiang HJ,
   2. Zhang ZR,
   3. Shen BZ,
   4. et al

   . Quantification of angiogenesis by CT perfusion imaging in liver tumor of rabbit. Hepatobiliary Pancreat Dis Int 2009;8:168–73

   PubMed
5. 5.↵
   1. Gleich LL,
   2. Biddinger PW,
   3. Pavelic ZP,
   4. et al

   . Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 1996;18:343–46

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kupisz K,
   2. Chibowski D,
   3. Klatka J,
   4. et al

   . Tumor angiogenesis in patients with laryngeal cancer. Eur Arch Otorhinolaryngol 1999;256:303–05

   CrossRefPubMed
7. 7.↵
   1. Lentsch EJ,
   2. Goudy S,
   3. Sosnowski J,
   4. et al

   . Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters. Laryngoscope 2006;116:397–400

   CrossRefPubMed
8. 8.↵
   1. Waugh DJ,
   2. Wilson C

   . The interleukin-8 pathway in cancer. Clin Cancer Res 2008;14:6735–41

   Abstract/FREE Full Text
9. 9.↵
   1. Trellakis S,
   2. Bruderek K,
   3. Dumitru CA,
   4. et al

   . Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 2011;129:2183–93

   CrossRefPubMedWeb of Science
10. 10.↵
    1. De Larco JE,
    2. Wuertz BR,
    3. Furcht LT

    . The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 2004;10:4895–900

    Abstract/FREE Full Text
11. 11.↵
    1. Pourgholami MH,
    2. Morris DL

    . Inhibitors of vascular endothelial growth factor in cancer. Cardiovasc Hematol Agents Med Chem 2008;6:343–47

    CrossRefPubMed
12. 12.↵
    1. Liu Q,
    2. Wang HG

    . Anti-cancer drug discovery and development: Bcl-2 family small molecule inhibitors. Commun Integr Biol 2012;5:557–65

    CrossRefPubMed
13. 13.↵
    1. Zeitlin BD,
    2. Zeitlin IJ,
    3. Nor JE

    . Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents. J Clin Oncol 2008;26:4180–88

    Abstract/FREE Full Text
14. 14.↵
    1. Carmeliet P,
    2. Jain RK

    . Angiogenesis in cancer and other diseases. Nature 2000;407:249–57

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Mehrad B,
    2. Keane MP,
    3. Strieter RM

    . Chemokines as mediators of angiogenesis. Thromb Haemost 2007;97:755–62

    PubMedWeb of Science
16. 16.↵
    1. Singh S,
    2. Sadanandam A,
    3. Singh RK

    . Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis Rev 2007;26:453–67

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Nor JE,
    2. Christensen J,
    3. Mooney DJ,
    4. et al

    . Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 1999;154:375–84

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Kaneko T,
    2. Zhang Z,
    3. Mantellini MG,
    4. et al

    . Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res 2007;67:9685–93

    Abstract/FREE Full Text
19. 19.↵
    1. Christofakis EP,
    2. Miyazaki H,
    3. Rubink DS,
    4. et al

    . Roles of CXCL8 in squamous cell carcinoma proliferation and migration. Oral Oncol 2008;44:920–26

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Hoefling NL,
    2. McHugh JB,
    3. Light E,
    4. et al

    . Human papillomavirus, p16, and epidermal growth factor receptor biomarkers and CT perfusion values in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34:1062–66

    Abstract/FREE Full Text
21. 21.↵
    1. Zima A,
    2. Carlos R,
    3. Gandhi D,
    4. et al

    . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

    Abstract/FREE Full Text
22. 22.↵
    1. Surlan-Popovic K,
    2. Bisdas S,
    3. Rumboldt Z,
    4. et al

    . Changes in perfusion CT of advanced squamous cell carcinoma of the head and neck treated during the course of concomitant chemoradiotherapy. AJNR Am J Neuroradiol 2010;31:570–75

    Abstract/FREE Full Text